AbbVie traded at $165.44 this Wednesday June 5th, increasing $3.32 or 2.05 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 1.85 percent. Over the last 12 months, its price rose by 22.16 percent. Looking ahead, we forecast AbbVie to be priced at 159.72 by the end of this quarter and at 156.81 in one year, according to Trading Economics global macro models projections and analysts expectations.